Breast Cancer as a late complication of treatment for lymphoma in children and adolescents
The treatment for pediatric patients affected by Hodgkin's lymphoma, including chemotherapy and radiotherapy, has offered a high survival rate, but may be responsible for the appearing of breast cancer in later form in these same people. The 20-year survival rate can reach 90% of patients suffering from Hodgkin's disease, but they may suffer sequelae, among which malignant secondary neoplasms, including breast cancer. Most studies show that the malignancy of breast tissue is the main secondary sequel to radiotherapeutics’ treatment for patients with Hodgkin's lymphoma in childhood.
Keywords: Breast Cancer; Hodgkin's Lymphoma; Radiotherapy.
2- Dörffel W, Riepenhausen M, Lüders H et al. Secondary Malignancies Following Treatment for Hodgkin’s Lymphoma in Childhood and Adolescence. Dtsch Arztebl Int. 2015 Mai 1; 112(18): 320-327.
3- Candela JL. CE: Cardiotoxicity and Breast Cancer as Late Effects of Pediatric and Adolescent Hodgkin Lymphoma Treatment. Am J Nurs. 2016 Apr;116(4):32-42.
4- Green DM, Hyland A, Barcos MP et al. Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. J Clin Oncol. 2000 Apr;18(7):1492-9.
5 - Von der Weid NX. Adult life after surviving lymphoma in childhood. Support Care Cancer. 2008 Apr;16(4):339-45.
6 - Beaty O 3rd, Hudson MM, Greenwald C et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol. 1995 Mar; 13(3): 603-9.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright policies & self-archiving
We are a RoMEO green journal.
|Author's Pre-print:||author can archive pre-print (ie pre-refereeing)|
|Author's Post-print:||author can archive post-print (ie final draft post-refereeing)|
|Publisher's Version/PDF:||author can archive publisher's version/PDF|
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Articles are published Under License of Creative Commons Attribution 3.0 License ©